Microarrays were developed and commercialized in the eighties. Since then, market has offered tremendous growth and hence has seen an influx of players vying fiercely for a share or this market. The Global DNA & Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%.

The oDNA segment accounted for the largest share – 98% – of the global DNA & Gene Chip (microarray) market in 2010. Gene expression currently forms the largest application market as gene expression products are used in a wide variety of research activities including life sciences research, clinical diagnostics, biodefense and agriculture. While this application contributed 28% to the Global DNA & Gene Chip (microarray) market revenues in 2010, cancer diagnosis, and treatment application is expected to dominate the applications market by 2015; accounting for about 24% share in the market.

North America dominated the global DNA & Gene Chip (microarray) market with a 45% share in 2010. However, this share is likely to drop down to about 37% in 2015 as the market has already reached maturity. Growth is expected from the Asian economies, especially China, India, South Korea, and Singapore, where government funding and investments in biotechnology play major roles.

Major players in this market include Affymetrix, Inc. (U.S.), Illumnia, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Roche NimbleGen (U.S.), and Sequenom Inc, (U.S.). New product launches, agreements and collaborations, partnerships, mergers and acquisitions, and geographic expansion were some of the major strategies adopted by the players to gain a competitive edge. Increasing demand from the Asian countries has resulted in players, such as Affymetrix, Inc. Illumina, Inc., and SurModics, Inc. (U.S.) amongst others adopt various strategies for market expansion. Singapore now accounts for half the production of DNA Microarrays with two major giants having shifted their manufacturing bases to the country.

This analyst briefing focuses on the global DNA & Gene Chip (microarray) market over the period 2008-2015. The agenda for the briefing includes discussion on key high growth markets, marking the growth trend in the DNA microarray types and applications market. Furthermore, a briefing will be conducted on the competitive scenario and geographic trends and opportunities in the macro- and micro-markets with respect to North America, Europe, Asia, and Rest of the World.

About MarketsandMarkets

MarketsandMarkets (M&M) is a global market research and consulting company based in the U.S. We publish strategically analyzed market research reports and serve as a business intelligence partner to Fortune 500 companies across the world. MarketsandMarkets also provides multi-client reports, company profiles, databases, and custom research services.

M&M covers thirteen industry verticals; including advanced materials, automotives and transportation, banking and financial services, biotechnology, chemicals, consumer goods, energy and power, food and beverages, industrial automation, medical devices, pharmaceuticals, semiconductor and electronics, and telecommunications and IT.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository. To know more about us and our reports, please visit our website www.marketsandmarkets.com

Note: An email containing the Login Details and Time of the Analyst Briefing will be sent to you soon after your registration.